Gains in access to antiretroviral treatment come with some costs

April 27, 2009

In this week's PLoS Medicine magazine, Yibeltal Assefa, from the National HIV/AIDS Prevention and Control Office in Addis Ababa, and colleagues describe the successes and challenges of the scale-up of antiretroviral treatment (ART) across Ethiopia. They report remarkable achievements in expansion of access to ART and to HIV counseling and testing (HCT), while managing to maintain the performance of other health programs such as tuberculosis and maternal and child health services. Task shifting to the health officers and health extension workers is thought to be responsible for these successes, say the authors.

At the same time, however, HIV prevention interventions and the management of chronic care patients are lagging behind now in Ethiopia. The authors say this may be due to lack of attention to these health care areas and to physicians leaving the public sector for non-governmental organizations (NGOs), including AIDS-related NGOs. They say urgent attention is needed in the areas of HIV prevention, management of chronic care patients, and retention of doctors in the public sector to ensure an effective and sustainable health system in Ethiopia.
-end-
Funding: No specific funding supported the production of this article.

Citation: Assefa Y, Jerene D, Lulseged S, Ooms G, Van Damme W (2009) Rapid Scale-Up of Antiretroviral Treatment in Ethiopia: Successes and System-Wide Effects. PLoS Med 6(4): e1000056. doi:10.1371/journal.pmed.1000056

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.1000056

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-06-04-assefa.pdf

CONTACT:
Yibeltal Assefa
National HIV/AIDS Prevention and Control Office
Health Programs
African Avenue, Dembel City Centre
Addis Ababa 00251
Ethiopia
+ 251911254246
yibeltalassefa343@gmail.com

PLOS

Related HIV Prevention Articles from Brightsurf:

Many practitioners are not prescribing HIV prevention medication, study finds
Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.

State laws key to HIV prevention efforts
HIV prevention remains a public health priority in the United States.

Use of PrEP for HIV prevention among at-risk teens in US
Nearly 60 articles were reviewed to assess the rate of preexposure prophylaxis (PrEP) use for HIV prevention among at-risk teens in the United States and to provide recommendations for how to improve access to and use of PrEP.

New high-cost HIV prevention drug: 'Better' isn't worth it
A newly approved drug for HIV pre-exposure prophylaxis (PrEP) is unlikely to confer any discernible health benefit over generic alternatives and may undermine efforts to expand access to HIV prevention for the nation's most vulnerable populations, according to a new study appearing March 9 in the Annals of Internal Medicine.

Sex workers' preferences for HIV prevention center on convenience
Preventing HIV in sex workers is a powerful tool in lowering the worldwide burden of the disease, and a new study could help ensure that high-risk women take advantage of medical safeguards.

Online intervention shows promise in HIV prevention
A team led by José Bauermeister, Ph.D., M.P.H., Presidential Professor of Nursing and Director of the Program on Sexuality, Technology, & Action Research (PSTAR), at the University of Pennsylvania School of Nursing (Penn Nursing) designed the My Desires & Expectations (myDEx) tool to address cognitive and emotional factors that influence YGBMSM sexual decision-making when seeking partners online. myDEx was pilot tested in a randomized trial over 90 days with 180 YGBMSM participants.

Prevention, treatment efforts reduce HIV infection among transgender women
Programs to prevent HIV in transgender women are helping to lower the rate of new infection but better care and treatment of this vulnerable population is still needed, especially among those of lower income or people of color, according to a new Rutgers study.

Meeting the challenge of engaging men in HIV prevention and treatment
A new commentary from National Institutes of Health scientists asserts that engaging men in HIV prevention and care is essential to the goal of ending the HIV pandemic.

New guidelines for treatment and prevention of HIV infection in adults
Experts have updated recommendations for the use of antiretroviral drugs in the treatment and prevention of HIV infection.

Wider access to HIV prevention drugs still needed
Anti-HIV drugs are highly effective, yet new infections continue because not everyone has equal access to treatment.

Read More: HIV Prevention News and HIV Prevention Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.